Filing Details

Accession Number:
0001317757-12-000015
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-02 16:21:43
Reporting Period:
2012-03-01
Filing Date:
2012-03-02
Accepted Time:
2012-03-02 16:21:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
792977 Amag Pharmaceuticals Inc. AMAG Pharmaceutical Preparations (2834) 042742593
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242616 E Frank Thomas 100 Hayden Avenue
Lexington MA 02421
Coo, Interim Ceo And President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-01 500 $15.81 1,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchase reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person.